mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.01 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |